✦ LIBER ✦

Resistance risk evaluation, “a European regulatory perspective”

✍ Scribed by Paul K Leonard

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rosiglitazone: a European regulatory per

✍ E. Blind; K. Dunder; P. A. de Graeff; E. Abadie 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 128 KB

Regulatory reform and liberalization: A

✍ David Encaoua 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 976 KB

A European perspective on immunogenicity

✍ Schneider, Christian K; Papaluca, Marisa; Kurki, Pekka 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Regulatory aspects of drug dissolution f

✍ Christina Graffner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Evaluating disease-modifying effects of

✍ Cristina Sampaio 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Regulatory agencies, pharmaceutical info

✍ Rafael Bauschke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 231 KB